Внешняя среда и развивающийся организм - Баранов В.С.
Скачать (прямая ссылка):
Cavic E., Webb Т. E. 1972. Modification of ornithine decarboxylase by factors which effect liver regeneration.— Biochim. et biophys. act», 262, p. 5-16—554.
Сho iib в S., К rets \V., Uchida K., Murphy M. L. 19G8. The teratogenic effect of 1-6-D-arabinofuranosylcytosine in the rat. Protection by deoxycytidine — Biochem. and Pharmacol., 17, p. 1213—1216.
Chaube S., Murphy SI. L. 1966. The effects of hydroxyurea and related compounds on the rat fetus.— Cancer Res., 20, p. 1448—1457.
Chaube S., Murphy M. L. 1968. The, teratogenic effects of recent drugs active in cancer chemotherapy.— Teratology, 3, p. 181—237.
Chaube S., Murphy М. I.-. 1973. Protective effects of deoxycy tidy lie acid (CdMP) on hydroxyuria-induced malformation in rats.— Teratology, 7, p. 79—88.
Спи M. Y., Fischer C. A. 1965. Comparative studies of leukemic cells sensitive and resistant to cytosine arabinoside.— Bio-ehem. and Pharmacol., 14, p. 333—341.
Clhak A., Weiss 7. W., Pitot H. C. 1974. Characterisation of polyribosomes and maturation of rihosomal RNA in hepatoma cells treated with 5 azacytidine.— Cancer Res., 34, p. 3003—3010.
Cohen S. S. 1971. On the nature Ihyminless death.— Ann. N. Y., Acad. Sci., 186, p. 292—301.
Colltman A. PP., Colleman D. K.,Werner I.
1970. The reversible control of animal cell differentiation by the thymidine analog 5-bromodeoxvuridine.— lixptl ('.ell Res., 59, p. 319—328.
Dagg C. P. i960. Sensitive stages for the production of developmental abnormalities in juice with 5-fluorouracil.— Amer. J. Anat., 106, p. 89—96.
Dagg C. P. 1963. The interaction of environmental stimuli and inherited susceptibility to congenital deformity.—Amer. Zool., 3, p. 223—233.
Dagg C. P. 1907. Combined action of fluo-rouracil and two mutant genes on limb development in the mouse.— J. Tlxptl Zool., 164, p. 479—489.
Dagg C. P., Doer г A., OJfuU Cl. 1966. Incorporation of 5-fluorouraeil-2-Cu bv mouse embryos.— Biol. Neonat., 10, p. 32—16.
David J., Gordon I. S., Rutler W. I. 1974. Increased thermal stability of chromatin containing 5-bromodeOxyuridine-substitu-ted DNA.— Proc. Nat. Acad. Sci. U.S.A., 71, p. 2808—2812.
Degenhardt К. H. 1966. Entwicklungsent* gleisimg spe/.iellcr Organanlagen.— Na-turwiss. Rundschau, 19, S. 13.
Degenhard K. U. 1969. A model in comparative leratogenesis. 11. Response to 5-
flumo-2-duoxycytidine at successive stages in organogenesis of mice of strains C57BL/0J iranfm and G57BL/10Jfm — + +Ld.— Teratology, 2, p. 345—350.
Ucnenhardt K. //., Frdnz J. 1969. Models in comparal.fVH teratogenesis.— Arch. Biol., 80, p. 257—20$.
DeonKtj К. М., Bymes J. /., Snrwdrk B. J., So A. G. 1074.. The of fee I. of 6-mercapto-purinc and il.s derivatives on mammalian RNA-depcndont RNA synthesis.— Biochem. and Biophys. Res. Comm u us, 56, p. 227—233.
Didcock K„ Jackson D.. Robson J. M. 1956. The action of some nncleotoxic substan ues on pregnancy.—Brit. Л. Pharmacol.,
11. p. 437—441.
Etferd II. L., У reuse .V., Pasamani F. .4., Norms II. P. 107(1. Ribonucleotide reductase and cell proliferation. I. Variations ol ribonucleotide reductase activity with tumour growth rate in a series of rat hcpAtomas.— J. Biol. Chein., 245, p. 5228—5233.
Elion G. В. 1007. Biochemistry and pharmacology of purine analogues.— Fed. Proc., 20. p. 808—903.
Elion G. B., Hackings G. II. 1965. Metabo-lio. basis for the action o! analogs of purines and pyrimidines-.— In: Advanced in Chemotherapy. V. 3, N. Y,— London, Acad. Press, p. 01—177.
Farber F.., Baserga П. 1909. Differential ef-foci.s ol hydroxyurea on the survival of proliferating cells in vivo.—Cancer Res., 20, p. 130— Ш.
Fcrm V. H. 1065. Teratogenic activity of hydroxyurea.— Lancet, i, p. 1339.
Foilman II., Hogenkamp П. P. C. 1971, Interaction of ribonucleotide reductase with ribonucleotide analog.— Riochemistrv, 10, p. 186—192.
Forsihoejel P. F. 1972. Histological studies on the effects of the teratogens 5-fluo-rouracil und 5-flnorodeoxyuridine on mouse limb development.— Genetics
(U.S.A.), 71, p. 17—IS.
Fridhandler L., Palmer XV. M. 19(58. Biosynthesis of RNA and DNA in rabbit
(i re implantation blastocysts. Effects of 5-lalogomtled deoxvuridines.— FertiL and Stcril., 19. p. 707—715.
Prtedkin M. 1070. Thymidylale synthetase.—In: Advanced in Enzyniology. V. 38. N. Y., Willy and Sans, p. 235—203.
Furlh I. S., Coken S. S. 196$. Inhibition of mammalian DNA polymerase by the 5'-triphosphal-e ol' 1 -jib-araliiuofuranosyl-cytosinc and the 5'-triphosphate of O-jJ-D-arabinofuivmosyladeninc.— Cancer. Res., 28. p. 2001—2<)fi7.
Gallo R. G., Perry S., Brsitman R. T. 1068. Inhibition of human leukocyte pyrimidine deoxynucleosidc synthesis by allo-
purinol and (J-mercaptopurine.— Bio-chcm. and Pharmacol., 17, p. 2185—2103.
Garner W. 1974. The effect of 5-bromodeo-Ayuridine on early mouse embryos in vitro —J. Embryol. and Exptl Morhpol.. 32, p. 849—855.
Georgalsos I. G.. Anionnglou ().. Gabri!:-des C. 1970. Incorporation of 0-iodo-2'-dooxyuriiline-5*1! into nuclear and mito-cliondrial DNA of normal huiI malignant mouse tissue.*.— Arch. Biochem. and Biophys., 130, p. 219—223.
